Med Pharma Trading DMCC

Dubai, UAE

We adhere strictly to international
standards of due quality assurance, safety control, logistics, and distribution across
all markets we serve

We adhere strictly
to international standards
of due quality assurance, safety control, logistics,
and distribution across all markets we serve

Regulatory Compliance

According to Registration Certificate No. DMCC191743, the company fully complies with the requirements of Law No. (4) of 2001 and the decree dated May 1, 2002 regarding the establishment of the Dubai Multi Commodities Centre (DMCC).

Business Focus

Comprehensive B2B pharmaceutical trading, promotion, and international distribution of generic medicines under the company's own trademark through a licensed partner network.

Registered & Licensed

Registered in Dubai, United Arab Emirates under Dubai Multi Commodities Centre (DMCC). Main business direction under License No. DMCC-827252: Trading in pharmaceutical products outside UAE

Regional Distribution

Our subsidiary “PHARMAVIST,” LLP provides properly licensed distribution in Kazakhstan and other regional markets (BIN 240740000886 dated 01.07.2024; legal and postal address: Bukhara Zhyrau Boulevard 27/5, Apt. 403, Almaty, Kazakhstan).

Regulatory Compliance

Business Focus

Comprehensive B2B pharmaceutical trading, promotion, and international distribution of generic medicines under the company's own trademark through a licensed partner network.

Registered & Licensed

Registered in Dubai, United Arab Emirates under Dubai Multi Commodities Centre (DMCC). Main business direction under License No. DMCC-827252: sale of pharmaceutical products outside the UAE.

Regional Distribution

Book a Call

Why us

We combine a solid regulatory foundation with an efficient international operating structure, ensuring reliable pharmaceutical trading, compliant distribution, and long-term partnership value

100%

Regulatory and Quality Compliance Full compliance across quality assurance, safety control, due delivery and distribution requirements

20+

Global pharma partners. 
‍We collaborate with more than 20 pharmaceutical companies across EU and Asia

70+

Products across key therapies 
‍Our portfolio includes more than 70 pharmaceutical products in oncology, hematology, multiple sclerosis, antibiotics, urology, anesthesiology, and other areas.

Business model
& Advantage

High-speed decision-making

High speed and a modern approach to decision-making allow faster approvals and efficient execution across key stages

Focus on successful outcomes

An operating model centered on measurable business results keeps strategy, implementation, and performance aligned

Market flexibility

Flexibility and rapid response to changing business conditions support stable execution across international markets

Client Priority

Our structure gives unconditional priority to clients’ interests and enables responsive support for regulatory and commercial needs

Strong expert team

Mastery of our team and preservation of it as our most valuable asset strengthen continuity and long-term partnership value

Portfolio growth

Dynamic development of our portfolio and constant sales growth support sustainable expansion in target markets.

We ensure full regulatory compliance across all markets

Compliance covers all stages, including quality assurance, safety control, licensed distribution and due delivery across international markets. We strictly adhere to all regulatory requirements regarding product movement from the manufacturer to the end consumer, regardless of the country of registration.

License No. DMCC-827252 defines the company’s principal activity as the sale of pharmaceutical products outside the UAE.

Registration Certificate No. DMCC191743 confirms the company’s compliance with the legal framework governing DMCC registration and operation in Dubai.

Licensed regional distribution is supported through PHARMAVIST, LLP in Kazakhstan and other regional markets.

Our Principles & Values

To be a reliable international partner and supplier providing products
and services that meet international standards.

To be a reliable international partner and supplier providing products and services that meet international standards.

Business Creed

To be a reliable partner and supplier offering top-tier products and services that meet international standards.

Core Values

Social responsibility, commitment, trust, quality, collaboration, connectivity, integrity, and consistency.

Mission

To prioritize the medical community of every target market by ensuring access to high-quality pharmaceutical products, especially first generics, in order to improve treatment quality for patients.

Value highlights

Social responsibility

We care for public health and safe treatment, placing the public interest above all else.

Commitment

We fulfill our promises and maintain a high level of quality in all aspects of our operations.

Trust and transparency

We build long-term relationships based on trust, openness, respect, and clear reporting.

Quality and collaboration

We impose high standards on manufacturers and partners while remaining open to multilateral partnership.

Integrity and consistency

Our decisions and actions are grounded in responsibility, reliability, and adherence to mutual agreements.

Examples from
the portfolio

Examples from the portfolio

Our full product portfolio can be requested
via the contact form below

Oncology / hematology

Abiraterone, Axitinib, Everolimus, Fulvestrant, Bendamustine, Bortezomib, Lenalidomide, Pomalidomide

Critical care / anesthesiology

Atracurium besylate, Fentanyl citrate, Midazolam, Nalbuphine, Norepinephrine, Propofol, Remifentanil hydrochloride, Rocuronium bromide.

Anti-infectives

Cefoperazone, Ceftriaxone, Fosfomycin, Levofloxacin, Linezolid, Piperacillin + Tazobactam, Tigecycline, Vancomycin, Voriconazole.

Other key areas

Esomeprazole, Ondansetron, Pantoprazole, Iron sucrose, Semaglutide, Dimethyl fumarate, Betahistine, Sertraline, Paracetamol, Solifenacin + Tamsulosin.

FAQ